CITOMIX

Manufacturer: Guna spa
Effective date: 2025-01-10
Label type: HUMAN OTC DRUG LABEL
Version: 8
Source: full-release
Hydrated at: 2026-06-01 02:30:14

Label at a glance#

ProductCITOMIX

Active ingredientPINEAPPLE, LENOGRASTIM, CENTELLA ASIATICA, INTERFERON GAMMA-1B, CANAKINUMAB, ALDESLEUKIN, BINETRAKIN, HUMAN INTERLEUKIN-6 (NONGLYCOSYLATED), SUS SCROFA SMALL INTESTINE MUCOSA LYMPH FOLLICLE, SUS SCROFA BONE MARROW, CRANBERRY, SUS SCROFA THYMUS

Label structure13 sections

Indications and uses

Immune Support during times of: seasonal colds and flu

Dosage and administration

Turn tube upside down and rotate cap to release pellets into cap. Unscrew cap and without touching pellets tip them into the mouth under the tongue. Allow to dissolve Take 15 minutes before meals.

Contacts and useful links#

PhoneLabel contact(484) 223-3500

Label contents#

Full prescribing information#

ACTIVE INGREDIENTS/PURPOSE

OTC - ACTIVE INGREDIENT SECTION

ANANASSA SATIVA 3X RELIEVES INFLAMMATION

GCSF 4C, 9C, 15C, 30C, INTERFERON GAMMA 4C IMMUNE SUPPORT

INTERLEUKIN 1 BETA 5C, INTERLEUKIN 2 5C, 7C, INTERLEUKIN 4 4C IMMUNE SUPPORT

INTERLEUKIN 6 7C, 9C, 15C, THYMUS GLAND 4C IMMUNE SUPPORT

HYDROCOTYLE ASIATICA 3X RELIEVES COLD SYMPTOMS

LYMPHATIC VESSEL 4C, MOUNTAIN CRANBERRY 3X RELIEVES INFLAMMATION, SWELLING, RESPIRATORY CONGESTION

MEDULLA OSSIS 4C RELIEVES NASAL CONGESTION

USES

OTC - PURPOSE SECTION

Immune Support during times of:

seasonal colds and flu

WARNINGS

OTC - STOP USE SECTION

Stop use and ask doctor if symptoms persist more than 5 days or worsen.

PREGNANCY

OTC - PREGNANCY OR BREAST FEEDING SECTION

If pregnant or breast-feeding ask a health care professional before use.

WARNINGS

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep this and all medicines out of reach of children

DIRECTIONS

OTC - WHEN USING SECTION

Turn tube upside down and rotate cap to release pellets into cap.
Unscrew cap and without touching pellets tip them into the mouth under the tongue.
Allow to dissolve
Take 15 minutes before meals.

QUESTIONS

OTC - QUESTIONS SECTION

Questions?: info@gunainc.com
tel. (484) 223-3500

DOSAGE & ADMINISTRATION SECTION

Take 15 minutes before meals
Adults and children 12 years and older 5 pellets 3 times per day
Children between 12 years and 6 years of age 3 pellets 3 times per day
Children under 6 years 1 pellet 3 times per day to be disoolved into a little water

WARNINGS SECTION

Stop use and ask doctor if symptoms persist more than 5 days or worsen.
If pregnant or breast-feeding ask a health professional before use.
Keep out of reach of children.

INACTIVE INGREDIENT SECTION

Inactive ingredient: Sucrose.

INDICATIONS & USAGE SECTION

Immune support suring times of:

Seasonal colds and flu

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children

PRINCIPAL DISPLAY PANEL

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

5USCIT-E

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
bd1801bf-1b8e-49c6-894d-a4af5821c1ab	Product name	1	20161129
d45267e3-883a-4760-85b5-ebc565c21683	Product name	1	20150910

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
17089-076-20	2020-03-13	C162847	48780-1	9d75b9d0-3fdc-f424-e053-dadaa90a57ce	CITOMIX
17089-076-20	2020-01-31	C162847	48780-1	9d75b9d0-3fdc-f424-e053-dadaa90a57ce	CITOMIX

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
17089-076-20	CITOMIX	2 in 1 BOX	PELLET	2		8
17089-076-20	CITOMIX	4 g in 1 TUBE	PELLET	4		8

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
17089-076	CITOMIX (ALDESLEUKIN - BINETRAKIN - CANAKINUMAB - CENTELLA ASIATICA - CRANBERRY - HUMAN INTERLEUKIN-6 (NONGLYCOSYLATED) - INTERFERON GAMMA-1B - LENOGRASTIM - PINEAPPLE - SUS SCROFA BONE MARROW - SUS SCROFA SMALL INTESTINE MUCOSA LYMPH FOLLICLE - SUS SCROFA THYMUS -) PELLET [GUNA SPA]	8	Current NDC, Legacy NDC, 2 package rows	20250112_23886c49-5992-4a59-af52-e24eb3c9fbc5.zip

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	SPL version
ALDESLEUKIN	ACTIVE INGREDIENT	M89N0Q7EQR	3
BINETRAKIN	ACTIVE INGREDIENT	751635Z921	3
CANAKINUMAB	ACTIVE INGREDIENT	37CQ2C7X93	3
CENTELLA ASIATICA	ACTIVE INGREDIENT	7M867G6T1U	3
CRANBERRY	ACTIVE INGREDIENT	0MVO31Q3QS	3
HUMAN INTERLEUKIN-6 (NONGLYCOSYLATED)	ACTIVE INGREDIENT	92QVL9080Y	3
INTERFERON GAMMA-1B	ACTIVE INGREDIENT	21K6M2I7AG	3
LENOGRASTIM	ACTIVE INGREDIENT	6WS4C399GB	3
PINEAPPLE	ACTIVE INGREDIENT	2A88ZO081O	3
SUS SCROFA BONE MARROW	ACTIVE INGREDIENT	VP2CN2G7Y8	3
SUS SCROFA SMALL INTESTINE MUCOSA LYMPH FOLLICLE	ACTIVE INGREDIENT	308LM01C72	3
SUS SCROFA THYMUS	ACTIVE INGREDIENT	7B69B0BD62	3
ALDESLEUKIN	ACTIVE MOIETY	M89N0Q7EQR	3
BINETRAKIN	ACTIVE MOIETY	751635Z921	3
CANAKINUMAB	ACTIVE MOIETY	37CQ2C7X93	3
CENTELLA ASIATICA	ACTIVE MOIETY	7M867G6T1U	3
CRANBERRY	ACTIVE MOIETY	0MVO31Q3QS	3
HUMAN INTERLEUKIN-6 (NONGLYCOSYLATED)	ACTIVE MOIETY	92QVL9080Y	3
INTERFERON GAMMA-1B	ACTIVE MOIETY	21K6M2I7AG	3
LENOGRASTIM	ACTIVE MOIETY	6WS4C399GB	3
PINEAPPLE	ACTIVE MOIETY	2A88ZO081O	3
SUS SCROFA BONE MARROW	ACTIVE MOIETY	VP2CN2G7Y8	3
SUS SCROFA SMALL INTESTINE MUCOSA LYMPH FOLLICLE	ACTIVE MOIETY	308LM01C72	3
SUS SCROFA THYMUS	ACTIVE MOIETY	7B69B0BD62	3
SUCROSE	INACTIVE INGREDIENT	C151H8M554	3

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 15 matching rows.

CITOMIX
ALDESLEUKIN - BINETRAKIN - CANAKINUMAB - CENTELLA ASIATICA - CRANBERRY - HUMAN INTERLEUKIN-6 (NONGLYCOSYLATED) - INTERFERON GAMMA-1B - LENOGRASTIM - PINEAPPLE - SUS SCROFA BONE MARROW - SUS SCROFA SMALL INTESTINE MUCOSA LYMPH FOLLICLE - SUS SCROFA THYMUS -
SUCROSE
PINEAPPLE
LENOGRASTIM
CENTELLA ASIATICA
INTERFERON GAMMA-1B
CANAKINUMAB
ALDESLEUKIN
BINETRAKIN
HUMAN INTERLEUKIN-6 (NONGLYCOSYLATED)
SUS SCROFA SMALL INTESTINE MUCOSA LYMPH FOLLICLE
SUS SCROFA BONE MARROW
CRANBERRY
SUS SCROFA THYMUS

NDC Codes#

Product NDC, Package NDC table
Product NDC	Package NDC
17089-076	17089-076-20

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 13 matching rows.

Name, UNII, Kind table
Name	UNII	Kind
SUCROSE	C151H8M554	IACT
PINEAPPLE	2A88ZO081O	ACTIB
LENOGRASTIM	6WS4C399GB	ACTIB
CENTELLA ASIATICA	7M867G6T1U	ACTIB
INTERFERON GAMMA-1B	21K6M2I7AG	ACTIB
CANAKINUMAB	37CQ2C7X93	ACTIB
ALDESLEUKIN	M89N0Q7EQR	ACTIB
BINETRAKIN	751635Z921	ACTIB
HUMAN INTERLEUKIN-6 (NONGLYCOSYLATED)	92QVL9080Y	ACTIB
SUS SCROFA SMALL INTESTINE MUCOSA LYMPH FOLLICLE	308LM01C72	ACTIB
SUS SCROFA BONE MARROW	VP2CN2G7Y8	ACTIB
CRANBERRY	0MVO31Q3QS	ACTIB
SUS SCROFA THYMUS	7B69B0BD62	ACTIB

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 2 · 62 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredient	IID ingredient	UNII	Dosage form / route	Potency	Maximum daily exposure	Match
SUCROSE	SUCROSE	C151H8M554	TABLET, CHEWABLE / ORAL		7258 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	WAFER / ORAL	155.2 mg		Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	CAPSULE, COATED, EXTENDED RELEASE / ORAL		86 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	GRANULE / ORAL	NA		Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TABLET, COATED / ORAL	516.42 mg		Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TABLET, DELAYED RELEASE / ORAL	295.33 mg		Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	POWDER, FOR SOLUTION / ORAL		38666 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	POWDER / ORAL		27768 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	LIQUID / ORAL		37500 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TABLET, FILM COATED / ORAL		145 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TABLET, FILM COATED, EXTENDED RELEASE / ORAL	119.12 mg		Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	GRANULE, FOR SUSPENSION / ORAL		31885 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	ELIXIR / ORAL		18000 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	SUSPENSION/ DROPS / ORAL		3750 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	DROPS / ORAL	NA		Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	CONCENTRATE / ORAL		4800 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	GRANULE, FOR SUSPENSION, EXTENDED RELEASE / ORAL		18790 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TABLET, FILM COATED / ORAL		145 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	POWDER, FOR SUSPENSION / ORAL		40017 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	DROPS / ORAL	NA		Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TABLET, CHEWABLE / ORAL		7258 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	SUSPENSION, EXTENDED RELEASE / ORAL		5400 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	SOLUTION / ORAL		70000 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	POWDER / ORAL		27768 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	WAFER / ORAL	155.2 mg		Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	PASTILLE / ORAL	426 mg		Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	SUSPENSION / ORAL		48209 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TABLET / ORAL		4249 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TABLET, EXTENDED RELEASE / ORAL	284.54 mg		Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TABLET, COATED / ORAL	516.42 mg		Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	LIQUID / ORAL		37500 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	GRANULE / ORAL	NA		Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	SUSPENSION/ DROPS / ORAL		3750 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TROCHE / ORAL	NA		Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	CAPSULE / ORAL		3568 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	CAPSULE, COATED PELLETS / ORAL	59.8 mg		Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	CAPSULE, DELAYED RELEASE / ORAL		955 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	GRANULE, FOR SOLUTION / ORAL		42596 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	CAPSULE, EXTENDED RELEASE / ORAL		619 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	CAPSULE, COATED, EXTENDED RELEASE / ORAL		86 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	SUSPENSION, EXTENDED RELEASE / ORAL		5400 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	CAPSULE, EXTENDED RELEASE / ORAL		619 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	CAPSULE, DELAYED RELEASE / ORAL		955 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TROCHE / ORAL	NA		Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	GRANULE, FOR SOLUTION / ORAL		42596 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	SYRUP / ORAL		46400 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	PASTILLE / ORAL	426 mg		Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TABLET / ORAL		4249 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	POWDER, FOR SUSPENSION / ORAL		40017 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TABLET, EXTENDED RELEASE / ORAL	284.54 mg		Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TABLET, FILM COATED, EXTENDED RELEASE / ORAL	119.12 mg		Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	SUSPENSION / ORAL		48209 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	CONCENTRATE / ORAL		4800 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	GRANULE, FOR SUSPENSION / ORAL		31885 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TABLET, DELAYED RELEASE / ORAL	295.33 mg		Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	SOLUTION / ORAL		70000 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	SYRUP / ORAL		46400 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	GRANULE, FOR SUSPENSION, EXTENDED RELEASE / ORAL		18790 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	CAPSULE / ORAL		3568 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	ELIXIR / ORAL		18000 mg	Exact identifier — unii+route 62 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
CITOMIX	ALDESLEUKIN - BINETRAKIN - CANAKINUMAB - CENTELLA ASIATICA - CRANBERRY - HUMAN INTERLEUKIN-6 (NONGLYCOSYLATED) - INTERFERON GAMMA-1B - LENOGRASTIM - PINEAPPLE - SUS SCROFA BONE MARROW - SUS SCROFA SMALL INTESTINE MUCOSA LYMPH FOLLICLE - SUS SCROFA THYMUS -	Guna spa	23886c49-5992-4a59-af52-e24eb3c9fbc5	2025-01-10	Warnings	Exact identifier ndc (package): 17089-076-20 ndc (product): 17089-076 ndc11 (package): 17089007620 spl id: 2b563c1a-771f-eb3f-e063-6394a90a618f spl set id: 23886c49-5992-4a59-af52-e24eb3c9fbc5

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.